Document:

Exhibit 10-AQ

AGREEMENT FOR CHANGE-OF-CONTROL BENEFIT

This Agreement for
Change-of-Control Benefit (the “Agreement”) is entered into effective January 19,
2006 (the “Effective Date”) between (each individually: Ron Ryan, Chief
Financial Officer, Alicia Lopez, General Counsel & Vice President
Administration, Joseph Forish, Vice President Human Resources, William Still,
Vice President Business Development, Dr Mark Popovsky, Vice President and
Corporate Medical Director, Brian Concannon, President Patient Division and
Regional Markets, Peter Allen, President Donor Division, Dr Ulrich Eckert,
President Europe, Ryoji Sakai, President Japan, and Remi Corlin, President
Asia), who is a member of the Haemonetics Corporation Operating Committee (the “Executive”),
and who resides at           
(intentionally blank contained in each original) , and Haemonetics
Corporation (the “Company”), a Massachusetts corporation with its principal
executive offices at 400 Wood Road, Braintree, Massachusetts 02184.

For so long as Executive
remains a member of the Company’s Operating Committee, then

1. If, following a “Change
of Control” (as defined below), Executive’s full time position with the Company
is eliminated or permanently transferred to a location other than its present
location, and following such elimination or transfer, the Company does not
offer to employ Executive in a comparable or better position in Executive’s
current location, on a full-time basis, at a comparable or better rate of pay,
then Executive shall be considered to have been constructively terminated and
shall be entitled to a severance payment and benefits as provided  below.

 2. For purposes of this Agreement, a “Change
of Control” shall mean a change of control of the Company of a nature that
would be required to be reported in response to Item 6(e) of Schedule 14A
of Regulation 14A promulgated under the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), whether or not the Company is, in fact, required
to comply therewith; provided that, without limitation, such a Change of
Control for purposes of this Agreement shall be deemed to have occurred if:

(i)            any “person” (as such term is used
in Sections 13(d) and 14(d) of the Exchange Act), other than the
Company, any trustee or other fiduciary holding securities under an employee
benefit plan of the Company or a corporation owned, directly or indirectly, by
the stockholder of the Company in substantially the same proportions as their
ownership of stock of the Company is or becomes the “beneficial owner” (as
defined in Rule 13d-3 under the Exchange Act), directly or
indirectly, of securities of the company representing 51% or more of the
combined voting power of the Company’s then outstanding securities;

(ii)           the stockholders of the Company
approve a merger or consolidation of the Company with any other corporation,
other than (A) a merger or consolidation which would result in the voting
securities of the Company outstanding immediately prior thereto continuing to
represent (either by remaining outstanding or by being converted into voting
securities of the surviving entity) at least 50% of the combined voting
securities of the Company or such surviving entity outstanding immediately
after such merger or consolidation, or (B) a merger or consolidation effected
to implement a recapitalization of the Company (or similar transaction) in
which no “person” (as herein above defined) acquires 50% or more of the
combined voting power of the Company’s then outstanding securities; or

(iii)          the stockholders of the Company
approve a plan of complete liquidation of the Company or an agreement for the
sale or disposition by the Company of all or substantially all of the Company’s
assets.

3. Upon termination, a severance payment shall be paid to Executive, in
lump sum, in an amount which equals 2 times the Executive’s then current
annualized Base Salary and target bonus.

4. To the extent
permitted by law and applicable insurance policies or plans, the Company shall
allow Executive to continue to participate in the Company’s medical and dental
plans for a period of twelve months from termination of employment, at employee
contribution rates applicable to other Company employees of the same coverage
election, provided however that as to U.S. based Executives, to the full extent
permitted by law, such continued participation in the Company’s medical and
dental plan shall satisfy twelve months of the Executive’s rights to any COBRA
benefit. If continuation of health care coverage is not permitted, then the
Company shall pay Executive the cash value of substantially equivalent health
care benefits received by Executive prior to the Change of Control.

5. The Company shall
provide to Executive substantially equivalent benefits or, at Executive’s
election, the cash value of substantially equivalent benefits provided by
Company’s life insurance and disability insurance policies, for a period of
twelve months from termination of employment, at employee contribution rates
applicable to other 

 

Company employees of the
same coverage election.

6. In the event it shall be determined that any
payment(s) or distribution(s) by the Company to or for the Executive’s
benefit (whether paid or payable or distributed or distributable pursuant to
the terms of this Agreement or otherwise, but determined without regard to any
additional payments required under this provision) (collectively, a “Payment”)
would be subject to the excise tax imposed by Section 4999 of the Internal
Revenue Code (including any succeeding provision) and/or any regulations, or
any interest or penalties are incurred by the Executive with respect to such
excise tax (such excise tax, together with any such interest and penalties, are
hereinafter collectively referred to as the “Excise Tax”), then the Executive
shall be entitled to receive an additional payment (a “Gross-Up Payment”) in
an amount such that after payment by the Executive of all taxes, including,
without limitation, any income taxes (and any interest and penalties imposed
with respect thereto) and Excise Tax imposed upon the Gross-Up Payment, the
Executive shall retain an amount of the Gross-Up Payment equal to the Excise
Tax (including any interest or penalties imposed with respect to such taxes)
imposed upon the Payment. The Executive shall cooperate with the Company in
providing information concerning Executive’s personal federal, state and local
income tax rate reasonably needed by the Company to calculate the Gross-Up
Payment.

7. The benefits
provided herein shall supercede any prior arrangement on Change of Control
benefits contained in any written employment agreement between the
Executive individually and the Company, but shall not supercede such
benefits under other arrangements, including (but not limited
to) accelerated vesting of benefits under any equity compensation
arrangements of the Company. To the extent that such benefits
are superceded in any such written employment agreement, the remaining
terms of such employment agreement shall remain in full force and effect. Nothing
herein shall constitute an agreement to offer employment or maintain employment
of Executive.

8. Executive shall serve
on the Company’s Operating Committee at the exclusive discretion of the
President and CEO, and nothing herein shall constitute an agreement to maintain
Executive’s membership on the Operating Committee.

9. This Agreement may not be amended except in a
written instrument, signed by both parties.

IN WITNESS WHEREOF, the undersigned have duly executed
and delivered this Agreement under seal as of the date first above written.

HAEMONETICS CORPORATION

By:

Brad Nutter

President and CEO

Date:

EXECUTIVE

(signed by respective
executives)_____________________________

[NAME]

[TITLE]

Date:EXHIBIT 10.1

FIFTH AMENDMENT TO CREDIT AGREEMENT

THIS FIFTH
AMENDMENT TO CREDIT AGREEMENT (this “Amendment”),
dated as of June 7, 2006 is entered into by and among the lenders identified on
the signature pages hereof (such lenders, together with their respective
successors and permitted assigns, are referred to hereinafter each individually
as a “Lender” and collectively as the “Lenders”), WELLS FARGO FOOTHILL, INC., a California
corporation, as administrative agent for the persons designated in the Credit Agreement
referred to below (in such capacity, together with its successors and assigns
in such capacity, “Agent”), and INFOCUS
CORPORATION, an Oregon corporation (“Borrower”).

RECITALS

A.            Borrower,
Agent and the Lenders have previously entered into that certain Credit
Agreement dated as of October 25, 2004, as amended by that certain First
Amendment to Credit Agreement, Security Agreement and Waiver, dated as of
December 3, 2004, that certain Second Amendment to Credit Agreement, dated as
of December 13, 2004, that certain Third Amendment to Credit Agreement and
Waiver dated May 6, 2005 and that certain Fourth Amendment to Credit Agreement,
Second Amendment to Security Agreement and Waiver dated November 4, 2005 (as so
amended or otherwise modified or supplemented from time to time, the “Credit
Agreement”), pursuant to which the Lenders have made certain loans and
financial accommodations available to Borrower. 
Terms used herein without definition shall have the meanings ascribed to
them in the Credit Agreement.

B.            The Lenders,
Agent and Borrower now wish to further amend the Credit Agreement on the terms
and conditions set forth herein

C.            Borrower is entering
into this Amendment with the understanding and agreement that, except as
specifically provided herein, none of Agent’s or any member of the Lender Group’s
rights or remedies set forth in the Credit Agreement or any other Loan Document
is being waived or modified by the terms of this Amendment.

AGREEMENT

NOW, THEREFORE, in
consideration of the foregoing and the mutual covenants herein contained, and
for other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties hereby agree as follows:

1.             Amendments to Credit
Agreement.

(a)           The defined term “Availability
Block” contained in Schedule 1.1 to the Credit Agreement is hereby
amended and restated to read as follows:

“ ‘Availability Block’
means the amount of $15,000,000.”

(b)           Section 11 of the Credit
Agreement is hereby amended by replacing the notice party Morrison &
Foerster LLP appearing therein with the following notice party:

1

 

BINGHAM MCCUTCHEN LLP

355 South Grand Avenue, Suite 4400

Los Angeles, California 90071

Attn:  Sandra L. Montgomery, Esq.

Fax No. (213) 680-6499

2.             Effectiveness of this
Amendment.  Agent must
have received the following items, in form and content acceptable to Agent,
before this Amendment, and the waivers provided for herein are effective.

(a)           Executed Amendment.  This Amendment fully executed in a sufficient
number of counterparts for distribution to all parties.

(b)           Representations and
Warranties.  The
representations and warranties contained herein shall be true and correct as of
the date hereof.

(c)           Other Documents and Legal
Matters.  All other documents and legal
matters in connection with the transactions contemplated by this Amendment
shall have been delivered or executed or recorded.

3.             Representations and
Warranties.  Borrower
represents and warrants as follows:

(a)           Authority.  Borrower has the requisite corporate power and
authority to execute and deliver this Amendment, and to perform its obligations
hereunder and under the Loan Documents (as amended or modified hereby and by
any amendments thereto referenced herein) to which it is a party.  The execution, delivery and performance by
Borrower of this Amendment and any amendment to any other Loan Document
referenced herein have been duly approved by all necessary corporate action and
no other corporate proceedings are necessary to consummate such transactions.

(b)           Enforceability.  This Amendment and any amendment to any other
Loan Document referenced herein have been duly executed and delivered by
Borrower.  This Amendment and each Loan
Document (as amended or modified hereby and by any amendments thereto
referenced herein) are the legal, valid and binding obligation of Borrower,
enforceable against Borrower in accordance with its terms, and is in full force
and effect.

(c)           Representations and
Warranties.  After
giving effect to this Amendment, the representations and warranties contained
in each Loan Document (other than any such representations or warranties that,
by their terms, are specifically made as of a date other than the date hereof)
are correct on and as of the date hereof as though made on and as of the date
hereof.

(d)           Due Execution.  The execution, delivery and performance of
this Amendment and any amendment to any other Loan Document referenced herein
are within the power of Borrower, have been duly authorized by all necessary
corporate action, have received all necessary governmental approval, if any,
and do not contravene any law or any contractual restrictions binding on
Borrower.

(e)           No Default.  No event has occurred and is continuing that
constitutes a Default or an Event of Default.

(f)            No Duress.  This Amendment and any amendment to any other
Loan Document referenced herein have been entered into without force or duress,
of the free will of Borrower.  Borrower’s

2

 

decision to enter into this
Amendment and any amendment to any other Loan Document referenced herein is a
fully informed decision and Borrower is aware of all legal and other
ramifications of such decision.

(g)           Counsel.  Borrower has read and understands this
Amendment and any amendment to any other Loan Document referenced herein, has
consulted with and been represented by legal counsel in connection herewith and
therewith, and has been advised by its counsel of its rights and obligations
hereunder and thereunder.

4.             Choice of Law.  The validity of this Amendment, its
construction, interpretation and enforcement, the rights of the parties
hereunder, shall be determined under, governed by, and construed in accordance
with the internal laws of the State of New York governing contracts only to be performed in that State.

5.             Counterparts.  This Amendment may be executed in any number
of counterparts and by different parties and separate counterparts, each of
which when so executed and delivered, shall be deemed an original, and all of
which, when taken together, shall constitute one and the same instrument.  Delivery of an executed counterpart of a
signature page to this Amendment by telefacsimile or other similar method of
electronic transmission shall be effective as delivery of a manually executed
counterpart of this Amendment.

6.             Reference to and Effect on
the Loan Documents.

(a)           Upon and after the
effectiveness of this Amendment, each reference in the Credit Agreement to “this
Agreement”, “hereunder”, “hereof” or words of like import referring to the
Credit Agreement, and each reference in the other Loan Documents to “the Credit
Agreement”, “thereof” or words of like import referring to the Credit
Agreement, shall mean and be a reference to the Credit Agreement as modified
and amended hereby.

(b)           Except as specifically
amended above, the Credit Agreement and all other Loan Documents, are and shall
continue to be in full force and effect and are hereby in all respects ratified
and confirmed and shall constitute the legal, valid, binding and enforceable
obligations of Borrower to the Lender Group.

(c)           The execution, delivery and
effectiveness of this Amendment shall not, except as expressly provided herein,
operate as a waiver of any right, power or remedy of the Agent  and Lender Group under any of the Loan
Documents, nor constitute a waiver of any provision of any of the Loan
Documents.

(d)           To the extent that any terms
and conditions in any of the Loan Documents shall contradict or be in conflict
with any terms or conditions of the Credit Agreement, after giving effect to
this Amendment, such terms and conditions are hereby deemed modified or amended
accordingly to reflect the terms and conditions of the Credit Agreement as
modified or amended hereby.

7.             Ratification.  Borrower hereby restates, ratifies and
reaffirms each and every term and condition set forth in the Credit Agreement,
as amended hereby, and the Loan Documents effective as of the date hereof.

8.             Estoppel.  To induce Agent and Lender Group to enter
into this Amendment and to continue to make advances to Borrower under the
Credit Agreement, Borrower hereby acknowledges and 

3

 

agrees that, as of the date
hereof, there exists no right of offset, defense, counterclaim or objection in
favor of Borrower as against any member of the Lender Group with respect to the
Obligations.

9.             Integration.  This Amendment, together with the other Loan
Documents, incorporates all negotiations of the parties hereto with respect to
the subject matter hereof and is the final expression and agreement of the
parties hereto with respect to the subject matter hereof.

10.           Severability.  In case any provision in this Amendment shall
be invalid, illegal or unenforceable, such provision shall be severable from
the remainder of this Amendment and the validity, legality and enforceability
of the remaining provisions shall not in any way be affected or impaired
thereby.

11.           Submission of Amendment.  The submission of this Amendment to the
parties or their agents or attorneys for review or signature does not
constitute a commitment by Agent or any of the Lenders to waive any of their
rights and remedies under the Loan Documents, and this Amendment shall have no
binding force or effect until all of the conditions to the effectiveness of
this Amendment have been satisfied as set forth herein.

[Signature
Page Follows]

 

4

IN WITNESS WHEREOF, the
parties have entered into this Amendment as of the date first above written.

	
   

  	
  INFOCUS
  CORPORATION,

  
	
   

  	
  an Oregon corporation

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Roger Rowe

  
	
   

  	
  Name:

  	
  Roger Rowe

  
	
   

  	
  Title:

  	
  Chief Financial Officer

  
	
   

  	
   

  	
   

  
	
   

  	
  WELLS
  FARGO FOOTHILL, INC.,

  
	
   

  	
  a California corporation,
  as Agent and a Lender

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
  /s/ Thomas Forbath

  
	
   

  	
  Name:

  	
  Thomas Forbath

  
	
   

  	
  Title: 

  	
  Vice President

  

 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}]]